# Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism

> **NCT00463346** · PHASE3 · COMPLETED · sponsor: **Yale University** · enrollment: 23 (actual)

## Conditions studied

- Alcohol Dependence
- Schizophrenia

## Interventions

- **DRUG:** Acamprosate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00463346
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463346, "Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00463346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*